Share Price and Basic Stock Data
Last Updated: December 12, 2025, 2:45 am
| PEG Ratio | 0.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Nucleus Software Exports Ltd operates in the IT Consulting and Software sector, a space that has seen robust growth in recent years. As of March 2025, the company reported a total revenue of ₹832 Cr, a notable increase from ₹634 Cr in the previous year. This upward trajectory is significant, reflecting a compound annual growth rate (CAGR) of approximately 31% over the past two years. The quarterly sales figures also indicate a consistent demand, with the most recent quarter ending March 2025 recording sales of ₹210 Cr. However, the subsequent quarter (June 2025) showed a slight decline to ₹195 Cr, suggesting potential seasonal fluctuations or market pressures. Despite this, the overall annual growth reflects a healthy business model, supported by a diverse clientele and an expanding product portfolio.
Profitability and Efficiency Metrics
Nucleus Software’s profitability metrics appear quite strong, with a net profit of ₹163 Cr for the fiscal year ending March 2025, compared to ₹128 Cr in the previous year. This translates to an impressive net profit margin of 19.58%, indicating effective cost management and operational efficiency. The company’s operating profit margin (OPM) stood at 20%, which, while slightly lower than the previous year, still showcases its ability to maintain profitability amid rising expenses. The interest coverage ratio is extraordinarily high at 312.81x, reflecting the company’s capacity to meet its debt obligations comfortably, although it has minimal borrowings of just ₹8 Cr. This financial cushion enhances the company’s resilience against economic downturns and provides flexibility for future investments.
Balance Sheet Strength and Financial Ratios
The balance sheet of Nucleus Software is characterized by a strong reserve position, with total reserves reported at ₹822 Cr as of September 2025, up from ₹788 Cr in March 2025. This robust reserve base not only supports operational stability but also indicates a prudent approach to capital management. The company’s low borrowing levels, with total borrowings recorded at merely ₹8 Cr, contribute to a healthy financial structure. The price-to-book value ratio stands at 2.59x, suggesting that the stock may be trading at a premium relative to its book value, which could be interpreted as a vote of confidence from investors. Additionally, a current ratio of 1.93x implies that Nucleus Software is well-positioned to cover its short-term liabilities, ensuring liquidity and operational continuity.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Nucleus Software reflects a solid foundation of promoter confidence, with promoters holding 73.59% of the equity as of September 2025. This significant stake suggests that the founding members remain deeply invested in the company’s future, which is often viewed positively by retail investors. Foreign institutional investors (FIIs) have increased their stake to 5.18%, indicating a growing interest from outside the domestic market. However, domestic institutional investors (DIIs) remain relatively low at 1.49%, which could suggest room for growth in local institutional interest. The total number of shareholders stands at 42,192, a slight decline from previous quarters, which may raise questions about retail investor sentiment. Overall, the concentration of promoter holdings could be a double-edged sword, as it reflects commitment but may also lead to volatility if there are any significant changes in the management structure.
Outlook, Risks, and Final Insight
Looking ahead, Nucleus Software’s growth potential remains strong, supported by its solid financials and operational efficiencies. However, risks do exist. The slight decline in quarterly revenue could signal potential market saturation or increased competition in the IT sector. Additionally, while the company’s low debt levels are a strength, they also highlight a conservative growth strategy, which may limit aggressive expansion efforts. Investors may also need to consider the impact of macroeconomic factors, such as global IT spending trends and regional economic conditions, which could influence future earnings. Overall, while Nucleus Software appears to be on a solid footing, investors should remain vigilant regarding market dynamics and the company’s ability to adapt to an ever-evolving technology landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Nucleus Software Exports Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 3.38 Cr. | 225 | 225/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 12.5 Cr. | 21.2 | 21.2/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 115 Cr. | 70.6 | 101/17.6 | 56.2 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 11.8 Cr. | 40.8 | 64.9/33.1 | 8.00 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 25.8 Cr. | 75.0 | 200/67.0 | 17.5 | 15.0 | 1.33 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 122,555.06 Cr | 815.67 | 46.90 | 158.22 | 0.78% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 129 | 130 | 169 | 206 | 207 | 205 | 204 | 210 | 195 | 202 | 206 | 229 | 218 |
| Expenses | 114 | 119 | 121 | 123 | 144 | 153 | 156 | 152 | 166 | 170 | 172 | 154 | 184 |
| Operating Profit | 15 | 11 | 48 | 83 | 63 | 52 | 48 | 58 | 29 | 32 | 33 | 74 | 34 |
| OPM % | 11% | 9% | 28% | 40% | 30% | 25% | 23% | 28% | 15% | 16% | 16% | 33% | 16% |
| Other Income | 6 | 9 | 9 | 10 | 13 | 12 | 12 | 14 | 15 | 19 | 16 | 17 | 18 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
| Profit before tax | 16 | 15 | 52 | 89 | 72 | 60 | 56 | 68 | 40 | 47 | 45 | 88 | 48 |
| Tax % | 31% | 26% | 26% | 24% | 25% | 26% | 26% | 24% | 24% | 29% | 22% | 26% | 27% |
| Net Profit | 11 | 11 | 38 | 68 | 54 | 45 | 41 | 52 | 30 | 33 | 35 | 65 | 35 |
| EPS in Rs | 4.02 | 4.12 | 14.32 | 25.27 | 20.01 | 16.65 | 15.43 | 19.47 | 11.28 | 12.35 | 13.06 | 24.19 | 13.15 |
Last Updated: August 1, 2025, 4:15 pm
Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 218.00 Cr.. The value appears to be declining and may need further review. It has decreased from 229.00 Cr. (Mar 2025) to 218.00 Cr., marking a decrease of 11.00 Cr..
- For Expenses, as of Jun 2025, the value is 184.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 154.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 30.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 40.00 Cr..
- For OPM %, as of Jun 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Mar 2025) to 16.00%, marking a decrease of 17.00%.
- For Other Income, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 40.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 30.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.15. The value appears to be declining and may need further review. It has decreased from 24.19 (Mar 2025) to 13.15, marking a decrease of 11.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:21 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 346 | 353 | 349 | 372 | 412 | 484 | 521 | 514 | 497 | 634 | 826 | 832 | 855 |
| Expenses | 278 | 287 | 318 | 319 | 353 | 405 | 427 | 384 | 460 | 478 | 606 | 664 | 681 |
| Operating Profit | 68 | 66 | 31 | 54 | 59 | 79 | 94 | 129 | 37 | 157 | 220 | 168 | 173 |
| OPM % | 20% | 19% | 9% | 14% | 14% | 16% | 18% | 25% | 7% | 25% | 27% | 20% | 20% |
| Other Income | 24 | 33 | 26 | 32 | 29 | 27 | 37 | 39 | 35 | 34 | 51 | 66 | 69 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 8 | 12 | 12 | 11 | 7 | 10 | 14 | 14 | 15 | 19 | 15 | 15 | 14 |
| Profit before tax | 83 | 87 | 44 | 74 | 80 | 96 | 117 | 154 | 56 | 171 | 256 | 219 | 227 |
| Tax % | 23% | 25% | 26% | 11% | 22% | 23% | 24% | 23% | 26% | 25% | 25% | 26% | |
| Net Profit | 64 | 65 | 32 | 66 | 63 | 75 | 89 | 118 | 41 | 128 | 192 | 163 | 168 |
| EPS in Rs | 19.87 | 19.98 | 10.03 | 20.43 | 21.54 | 25.67 | 30.64 | 40.62 | 15.28 | 47.73 | 71.56 | 60.88 | 62.75 |
| Dividend Payout % | 30% | 25% | 50% | 24% | 37% | 35% | 29% | 22% | 46% | 21% | 17% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1.56% | -50.77% | 106.25% | -4.55% | 19.05% | 18.67% | 32.58% | -65.25% | 212.20% | 50.00% | -15.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -52.33% | 157.02% | -110.80% | 23.59% | -0.38% | 13.92% | -97.84% | 277.45% | -162.20% | -65.10% |
Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 72% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 36% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 11:50 am
Balance Sheet
Last Updated: December 10, 2025, 3:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 29 | 29 | 29 | 29 | 27 | 27 | 27 | 26 | 26 |
| Reserves | 365 | 406 | 425 | 503 | 432 | 480 | 532 | 643 | 467 | 584 | 751 | 788 | 822 |
| Borrowings | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 6 | 2 | 6 | 5 | 2 | 8 |
| Other Liabilities | 116 | 118 | 123 | 131 | 184 | 177 | 196 | 206 | 241 | 257 | 332 | 337 | 373 |
| Total Liabilities | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
| Fixed Assets | 61 | 58 | 54 | 48 | 48 | 47 | 57 | 50 | 59 | 50 | 59 | 61 | 77 |
| CWIP | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
| Investments | 224 | 170 | 245 | 441 | 387 | 424 | 475 | 635 | 480 | 525 | 649 | 641 | 676 |
| Other Assets | 228 | 328 | 281 | 176 | 210 | 214 | 231 | 200 | 198 | 298 | 406 | 451 | 477 |
| Total Assets | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 822.00 Cr.. The value appears strong and on an upward trend. It has increased from 788.00 Cr. (Mar 2025) to 822.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 337.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 77.00 Cr., marking an increase of 16.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 676.00 Cr.. The value appears strong and on an upward trend. It has increased from 641.00 Cr. (Mar 2025) to 676.00 Cr., marking an increase of 35.00 Cr..
- For Other Assets, as of Sep 2025, the value is 477.00 Cr.. The value appears strong and on an upward trend. It has increased from 451.00 Cr. (Mar 2025) to 477.00 Cr., marking an increase of 26.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
Notably, the Reserves (822.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 66.00 | 30.00 | 54.00 | 59.00 | 79.00 | 88.00 | 123.00 | 35.00 | 151.00 | 215.00 | 166.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Working Capital Days | -5 | 14 | 7 | -43 | -66 | -51 | -53 | -61 | -77 | -16 | -38 | -43 |
| ROCE % | 21% | 19% | 10% | 15% | 16% | 19% | 21% | 22% | 6% | 27% | 32% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| WhiteOak Capital Flexi Cap Fund | 167,297 | 0.26 | 16.9 | 113,333 | 2025-12-08 02:20:10 | 47.62% |
| WhiteOak Capital Mid Cap Fund | 63,549 | 0.16 | 6.42 | 45,586 | 2025-12-08 02:20:10 | 39.4% |
| WhiteOak Capital ELSS Tax Saver Fund | 13,802 | 0.32 | 1.39 | 4,324 | 2025-12-08 02:20:10 | 219.2% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Diluted EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Cash EPS (Rs.) | 67.53 | 77.01 | 54.73 | 21.03 | 45.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Revenue From Operations / Share (Rs.) | 316.08 | 308.72 | 237.00 | 185.73 | 176.84 |
| PBDIT / Share (Rs.) | 89.10 | 101.34 | 71.28 | 26.78 | 58.16 |
| PBIT / Share (Rs.) | 83.48 | 95.91 | 64.29 | 21.03 | 53.38 |
| PBT / Share (Rs.) | 83.19 | 95.55 | 63.91 | 20.73 | 52.96 |
| Net Profit / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| NP After MI And SOA / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| PBDIT Margin (%) | 28.18 | 32.82 | 30.07 | 14.41 | 32.88 |
| PBIT Margin (%) | 26.41 | 31.06 | 27.12 | 11.32 | 30.18 |
| PBT Margin (%) | 26.32 | 30.95 | 26.96 | 11.16 | 29.95 |
| Net Profit Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| NP After MI And SOA Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| Return on Networth / Equity (%) | 20.01 | 24.64 | 20.92 | 8.28 | 17.55 |
| Return on Capital Employeed (%) | 25.25 | 31.36 | 26.84 | 10.84 | 22.57 |
| Return On Assets (%) | 14.13 | 17.19 | 14.61 | 5.55 | 13.33 |
| Asset Turnover Ratio (%) | 0.73 | 0.83 | 0.74 | 0.56 | 0.56 |
| Current Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Quick Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Dividend Payout Ratio (NP) (%) | 20.53 | 13.97 | 14.66 | 42.58 | 7.38 |
| Dividend Payout Ratio (CP) (%) | 18.82 | 12.98 | 12.79 | 30.94 | 6.60 |
| Earning Retention Ratio (%) | 79.47 | 86.03 | 85.34 | 57.42 | 92.62 |
| Cash Earning Retention Ratio (%) | 81.18 | 87.02 | 87.21 | 69.06 | 93.40 |
| Interest Coverage Ratio (X) | 312.81 | 285.58 | 187.09 | 88.51 | 138.44 |
| Interest Coverage Ratio (Post Tax) (X) | 218.33 | 202.68 | 126.28 | 51.51 | 97.68 |
| Enterprise Value (Cr.) | 1988.60 | 3091.48 | 1658.15 | 1054.42 | 1353.67 |
| EV / Net Operating Revenue (X) | 2.39 | 3.74 | 2.61 | 2.12 | 2.64 |
| EV / EBITDA (X) | 8.48 | 11.40 | 8.69 | 14.71 | 8.01 |
| MarketCap / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| Retention Ratios (%) | 79.46 | 86.02 | 85.33 | 57.41 | 92.61 |
| Price / BV (X) | 2.59 | 4.07 | 2.80 | 2.25 | 2.08 |
| Price / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| EarningsYield | 0.07 | 0.06 | 0.07 | 0.03 | 0.08 |
After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.53. This value is within the healthy range. It has decreased from 77.01 (Mar 24) to 67.53, marking a decrease of 9.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 316.08. It has increased from 308.72 (Mar 24) to 316.08, marking an increase of 7.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 89.10. This value is within the healthy range. It has decreased from 101.34 (Mar 24) to 89.10, marking a decrease of 12.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.48. This value is within the healthy range. It has decreased from 95.91 (Mar 24) to 83.48, marking a decrease of 12.43.
- For PBT / Share (Rs.), as of Mar 25, the value is 83.19. This value is within the healthy range. It has decreased from 95.55 (Mar 24) to 83.19, marking a decrease of 12.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For PBDIT Margin (%), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 32.82 (Mar 24) to 28.18, marking a decrease of 4.64.
- For PBIT Margin (%), as of Mar 25, the value is 26.41. This value exceeds the healthy maximum of 20. It has decreased from 31.06 (Mar 24) to 26.41, marking a decrease of 4.65.
- For PBT Margin (%), as of Mar 25, the value is 26.32. This value is within the healthy range. It has decreased from 30.95 (Mar 24) to 26.32, marking a decrease of 4.63.
- For Net Profit Margin (%), as of Mar 25, the value is 19.58. This value exceeds the healthy maximum of 10. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.01. This value is within the healthy range. It has decreased from 24.64 (Mar 24) to 20.01, marking a decrease of 4.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.25. This value is within the healthy range. It has decreased from 31.36 (Mar 24) to 25.25, marking a decrease of 6.11.
- For Return On Assets (%), as of Mar 25, the value is 14.13. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 14.13, marking a decrease of 3.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.83 (Mar 24) to 0.73, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.53. This value is within the healthy range. It has increased from 13.97 (Mar 24) to 20.53, marking an increase of 6.56.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 20. It has increased from 12.98 (Mar 24) to 18.82, marking an increase of 5.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.47. This value exceeds the healthy maximum of 70. It has decreased from 86.03 (Mar 24) to 79.47, marking a decrease of 6.56.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.18. This value exceeds the healthy maximum of 70. It has decreased from 87.02 (Mar 24) to 81.18, marking a decrease of 5.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 312.81. This value is within the healthy range. It has increased from 285.58 (Mar 24) to 312.81, marking an increase of 27.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 218.33. This value is within the healthy range. It has increased from 202.68 (Mar 24) to 218.33, marking an increase of 15.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,988.60. It has decreased from 3,091.48 (Mar 24) to 1,988.60, marking a decrease of 1,102.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 3.74 (Mar 24) to 2.39, marking a decrease of 1.35.
- For EV / EBITDA (X), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 8.48, marking a decrease of 2.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For Retention Ratios (%), as of Mar 25, the value is 79.46. This value exceeds the healthy maximum of 70. It has decreased from 86.02 (Mar 24) to 79.46, marking a decrease of 6.56.
- For Price / BV (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 4.07 (Mar 24) to 2.59, marking a decrease of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
- Net Profit Margin: 19.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.25% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.01% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 218.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15 (Industry average Stock P/E: 46.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 33-35, Thyagraj Nagar Market, New Delhi Delhi 110003 | investorrelations@nucleussoftware.com http://www.nucleussoftware.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S M Acharya | Chairman(NonExe.&Ind.Director) |
| Mr. Vishnu R Dusad | Managing Director |
| Mr. Anurag Mantri | Executive Director & COO |
| Mr. Parag Bhise | Executive Director & CEO |
| Mr. Shekar Viswanathan | Ind. Non-Executive Director |
| Dr. Ritika Dusad | Executive Director |
| Mr. Prakash Chandra Kandpal | Ind. Non-Executive Director |
| Ms. Yasmin Javeri Krishan | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Nucleus Software Exports Ltd?
Nucleus Software Exports Ltd's intrinsic value (as of 12 December 2025) is 657.98 which is 28.64% lower the current market price of 922.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,427 Cr. market cap, FY2025-2026 high/low of 1,378/724, reserves of ₹822 Cr, and liabilities of 1,230 Cr.
What is the Market Cap of Nucleus Software Exports Ltd?
The Market Cap of Nucleus Software Exports Ltd is 2,427 Cr..
What is the current Stock Price of Nucleus Software Exports Ltd as on 12 December 2025?
The current stock price of Nucleus Software Exports Ltd as on 12 December 2025 is 922.
What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is 1,378/724.
What is the Stock P/E of Nucleus Software Exports Ltd?
The Stock P/E of Nucleus Software Exports Ltd is 15.0.
What is the Book Value of Nucleus Software Exports Ltd?
The Book Value of Nucleus Software Exports Ltd is 322.
What is the Dividend Yield of Nucleus Software Exports Ltd?
The Dividend Yield of Nucleus Software Exports Ltd is 1.36 %.
What is the ROCE of Nucleus Software Exports Ltd?
The ROCE of Nucleus Software Exports Ltd is 22.6 %.
What is the ROE of Nucleus Software Exports Ltd?
The ROE of Nucleus Software Exports Ltd is 16.8 %.
What is the Face Value of Nucleus Software Exports Ltd?
The Face Value of Nucleus Software Exports Ltd is 10.0.